Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans
Primary Purpose
Insulin Resistance
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
human insulin
Sponsored by
About this trial
This is an interventional basic science trial for Insulin Resistance focused on measuring Intranasal insulin
Eligibility Criteria
Inclusion Criteria:
- Male volunteers (lean or overweight/obese)
- HbA1c <6.0%
- Age between 18 and 40 years
- healthy as assessed by physician
- Understanding the explanations about the study and instructions
Exclusion Criteria:
- non-removable metal parts in or on the body
- Persons with reduced temperature sensation and / or increased sensitivity to warming of the body
- Cardiovascular disease can not be excluded, such as evident coronary heart disease, congestive heart failure NYHA greater than 2, history of coronary artery disease
- History of stroke
- Persons with a hearing disorder or increased sensitivity to loud noises
- People with claustrophobia
- Subjects in which less than 3 months have passed since surgery
- Simultaneous participation in other studies
- Acute disease or infection within the last 4 weeks
- Neurological and psychiatric disorders
- Subjects with hemoglobin Hb <13g / dl
- Heparin-induced thrombocytopenia people with a (HIT) in prehistory
- Allergies to any of the used solutions/devices
Sites / Locations
- University of Tuebingen, Department of Internal Medicine IV
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
insulin nasal spray
placebo nasal spray
Arm Description
160 Units of human insulin as nasal spray
Nasal spray containing placebo solution
Outcomes
Primary Outcome Measures
Change in glucose infusion rate during hyperinsulinemic euglycemic glucose clamp from before to after nasal spray application in lean persons
Change in endogenous glucose production from before to after nasal spray application in lean persons
Will be assessed by tracer dilution technique.
Differences in insulin response between lean and overweight persons
Will be assessed as plasma insulin and C-peptide concentrations.
Secondary Outcome Measures
Autonomous nervous system activity
Will be assessed by analysis of heart rate variability.
Regional brain insulin sensitivity
Will be assessed on an additional study day by fMRI before and after intranasal insulin administration
Full Information
NCT ID
NCT02468999
First Posted
March 24, 2015
Last Updated
January 7, 2016
Sponsor
University Hospital Tuebingen
1. Study Identification
Unique Protocol Identification Number
NCT02468999
Brief Title
Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans
Study Type
Interventional
2. Study Status
Record Verification Date
January 2016
Overall Recruitment Status
Completed
Study Start Date
January 2015 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
December 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital Tuebingen
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Research in animals and first experiments in humans indicate that insulin action in the brain regulates peripheral insulin sensitivity. One major organ might be the liver. Previous studies in humans showed that the human brain is an insulin sensitive organ in lean but not in overweight/obese persons. Therefore, this study will include lean versus overweight/obese persons.
In this study, insulin action will be introduced by intranasal insulin administration in lean and overweight humans. As a control, placebo spray will be administered. To mimick the known spill over of small amounts of intranasal insulin into circulation, a small bolus of insulin will be administered over 15 minutes following placebo spray application.
Peripheral insulin sensitivity will be assessed by hyperinsulinemic-euglycemic glucose clamp and glucose uptake and endogenous glucose production will be assessed by tracer dilution technique. Autonomous nervous system activity will be addressed by heart rate variability. Involved brain areas will be addressed by fMRI before and after nasal insulin application.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insulin Resistance
Keywords
Intranasal insulin
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
21 (Actual)
8. Arms, Groups, and Interventions
Arm Title
insulin nasal spray
Arm Type
Active Comparator
Arm Description
160 Units of human insulin as nasal spray
Arm Title
placebo nasal spray
Arm Type
Placebo Comparator
Arm Description
Nasal spray containing placebo solution
Intervention Type
Drug
Intervention Name(s)
human insulin
Primary Outcome Measure Information:
Title
Change in glucose infusion rate during hyperinsulinemic euglycemic glucose clamp from before to after nasal spray application in lean persons
Time Frame
Change from 70-90 min (before spray) to 170-210 min and to 280-300 min
Title
Change in endogenous glucose production from before to after nasal spray application in lean persons
Description
Will be assessed by tracer dilution technique.
Time Frame
Change from 70-90 min (before spray) to 170-210 min and to 280-300 min
Title
Differences in insulin response between lean and overweight persons
Description
Will be assessed as plasma insulin and C-peptide concentrations.
Time Frame
up to 210 minutes post nasal spray administration
Secondary Outcome Measure Information:
Title
Autonomous nervous system activity
Description
Will be assessed by analysis of heart rate variability.
Time Frame
baseline, 70-90 min, 170-210 min and 280-300 min
Title
Regional brain insulin sensitivity
Description
Will be assessed on an additional study day by fMRI before and after intranasal insulin administration
Time Frame
30 min
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Male volunteers (lean or overweight/obese)
HbA1c <6.0%
Age between 18 and 40 years
healthy as assessed by physician
Understanding the explanations about the study and instructions
Exclusion Criteria:
non-removable metal parts in or on the body
Persons with reduced temperature sensation and / or increased sensitivity to warming of the body
Cardiovascular disease can not be excluded, such as evident coronary heart disease, congestive heart failure NYHA greater than 2, history of coronary artery disease
History of stroke
Persons with a hearing disorder or increased sensitivity to loud noises
People with claustrophobia
Subjects in which less than 3 months have passed since surgery
Simultaneous participation in other studies
Acute disease or infection within the last 4 weeks
Neurological and psychiatric disorders
Subjects with hemoglobin Hb <13g / dl
Heparin-induced thrombocytopenia people with a (HIT) in prehistory
Allergies to any of the used solutions/devices
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andreas Fritsche, Prof. Dr.
Organizational Affiliation
University Hospital Tuebingen
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Tuebingen, Department of Internal Medicine IV
City
Tübingen
ZIP/Postal Code
72076
Country
Germany
12. IPD Sharing Statement
Citations:
PubMed Identifier
28174292
Citation
Heni M, Wagner R, Kullmann S, Gancheva S, Roden M, Peter A, Stefan N, Preissl H, Haring HU, Fritsche A. Hypothalamic and Striatal Insulin Action Suppresses Endogenous Glucose Production and May Stimulate Glucose Uptake During Hyperinsulinemia in Lean but Not in Overweight Men. Diabetes. 2017 Jul;66(7):1797-1806. doi: 10.2337/db16-1380. Epub 2017 Feb 7.
Results Reference
derived
Learn more about this trial
Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans
We'll reach out to this number within 24 hrs